GetPortalImpactFactorByIdResp(projectId=1, id=fec54833, cover=https://img.medsci.cn/images/journal/cover/2021/eLs_202109271316066560.jpg, fullname=MOLECULAR PHARMACOLOGY, abbr=MOL PHARMACOL, pyear=1965, frequence=Monthly, articleNumbers=4240, citedSelf2015=3.4, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0026-895X, greenSci=https://www.greensci.net/search?kw=0026-895X, scijournal=https://www.scijournal.org/impact-factor-of-MOL-PHARMACOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=2.892, medsciHotlight=3.852, medsciHotlight5year=6.48681, citescore=6.5, hIndex=198, impactFactor=3.6, orgnization=American Society for Pharmacology and Experimental Therapeutics, orgnizationUrl=http://www.aspet.org/, country=United States, countryCn=美国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 2区, smallclassCas=医学 3 区, website=http://molpharm.aspetjournals.org/, websiteHits=8779, guideForAuthor=null, guideForAuthorHits=4, submitWebsite=https://submit-molpharm.aspetjournals.org/, submitWebsiteHits=1481, content=Molecular Pharmacology welcomes manuscripts for consideration that report new information on drug action or selective toxicity at the molecular level. The Editors encourage submissions that shed light upon molecular mechanisms. These may include, for example, studies of receptors, signaling, pathways, enzymes,channels, and transcriptional mechanisms. Studies that report the development of novel reagents or technologies that are of broad applicability or yield new molecular insights are also encouraged. While Molecular Pharmacology attempts to publish studies with a strong component of biological experimentation, the journal also welcomes studies that involve molecular modeling relevant to drug design or drug action., totalCites=15265, brief=MOL PHARMACOL杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的优秀级杂志, articleType=论著,综述各类型文章都接收, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=MOL PHARMACOL杂志级别还可以,但是相对来说,比较冷门,关注人数偏少,有些可能是国内不太熟悉,但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿,稿源可能未必丰富,发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=fec54833'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br>
注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=3.95), GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.92), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.55), GetImpactFactorCiteScoreListResponse(year=2019, citescore=6.7), GetImpactFactorCiteScoreListResponse(year=2020, citescore=6.5)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=5.02), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=4.876), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=3.994), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=3.54), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=2.892)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=61/300), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=47/165)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0026-895X[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=MOLECULAR PHARMACOLOGY[ta], article_number=49, article_number_cn=3, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)